In February last year, Amy was diagnosed with Cushing's Syndrome - a rare condition caused by an excess of cortisol in the ...
"Doctors were chiming in in the comments and they were, like, 'No, no…something's really up. Your face looks so crazy.'" ...
A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...
Corcept Therapeutics' long-term goal is $3 billion revenue by 2029, driven by the new drug Relacorilant. Click here to read ...